July 15, 2014
IMPAQ International is pleased to announce that it has been awarded the Research, Measurement, Assessment, Design and Analysis (RMADA) indefinite delivery/indefinite quantity (IDIQ) by the U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services.
June 23, 2014
IMPAQ International is pleased to announce that it has been selected as one of The Washington Post Top Workplaces. “We are honored to have been selected for the award, particularly because the judges are our employees.” stated IMPAQ President Avi Benus. “At IMPAQ, we strive to create a work environment in which our employees can thrive collectively and individually.”
June 17, 2014
The U.S. Department of Labor (DOL) recently posted IMPAQ International’s report - Using Workforce Data Quality Databases to Develop and Improve Consumer Report Card Systems – on its website. Contracted by DOL’s Chief Evaluation Office (CEO), IMPAQ and its partners, New Horizons Economic Research and the Urban Institute, conducted a study to understand the connections between the Workforce Data Quality Initiative (WDQI) and state efforts to develop Consumer Report Card Systems (CRCSs).
May 12, 2014
IMPAQ International, a public policy research and evaluation firm, is proud to be have been awarded the 2014 James W. Rouse Diversity Award from the Chesapeake Human Resources Association (CHRA). The James W. Rouse Diversity Award honors the innovative strategies that businesses have developed and implemented to advance the concept and spirit of diversity. The award is given to the organization that demonstrates the very best diversity initiatives.
March 13, 2014
The Maryland Health Care Commission (MHCC), an independent agency whose mission is to plan for health system needs, recently posted IMPAQ International’s Evaluation of the Maryland Multi-Payor Patient Centered Medical Home Program (MMPP) report. The Maryland Health Care Commission launched the MMPP on April 14, 2011 as a three-year pilot in response to a legislative ma
March 07, 2014
IMPAQ International, a research, evaluation, technical assistance and technology solutions firm with offices in Columbia, MD, Washington, DC and Oakland, CA announced today that it has been awarded the United States GSA IT Schedule 70 contract as a small business. IT Schedule 70 is the largest, most widely used acquisition vehicle in the Federal Government. Under the contract, IMPAQ joins a federally approved list of select providers of IT services and solutions.
IMPAQ Reemployment and Eligibility Assessment Found To Meet Congressional "Near Top Tier" Evidence Standard
February 14, 2014
IMPAQ International announced today that the Company’s experimental evaluation of the Nevada Reemployment and Eligibility Assessment (REA) program has been identified by the Coalition for Evidence-Based Policy’s Top Tier Evidence Initiative as having met the Congressional "Near Top Tier" Evidence Standard.
February 05, 2014
IMPAQ International announced today that Dr. Teerachat Techapaisarnjaroenkij, a Senior Research Analyst with the company’s Labor Division, has been selected by the Eastern Economic Association (EEA) as the recipient of the group’s Eckstein Prize for 2011/2012.
January 27, 2014
IMPAQ International announced that Mr. Roman Ponos has joined the company as Vice President, International Development. In his new role he will lead the company’s efforts to consolidate and expand its growing international development portfolio, while also managing IMPAQ’s ongoing global projects.
IMPAQ International, RAND Corporation Research Indicates National Plan for Preventing Healthcare-Associated Infections Showing “Measurable Progress”
January 24, 2014
Independent evaluators have found that measurable progress in reducing the rates of some targeted healthcare-associated infections (HAIs) has been achieved under the umbrella of a national plan to prevent HAIs that was developed by the U.S. Department of Health and Human Services (HHS). The evaluation appears in a special February supplement to Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.